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Abstract
Cocaine-mediated repression of the histone methyltransferase (HMT) G9a has recently been 
implicated in transcriptional, morphological, and behavioral responses to chronic cocaine 
administration. Here, using a ribosomal affinity purification approach, we find that G9a repression 
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by cocaine occurs in both Drd1 (striatonigral)- and Drd2 (striatopallidal)-expressing medium spiny 
neurons (MSNs). Conditional knockout and overexpression of G9a within these distinct cell types, 
however, reveals divergent behavioral phenotypes in response to repeated cocaine treatment. Our 
studies further indicate that such developmental deletion of G9a selectively in Drd2 neurons 
results in the unsilencing of transcriptional programs normally specific to striatonigral neurons, 
and the acquisition of Drd1-associated projection and electrophysiological properties. This partial 
striatopallidal to striatonigral ‘switching’ phenotype in mice indicates a novel role for G9a in 
contributing to neuronal subtype identity, and suggests a critical function for cell-type specific 
histone methylation patterns in the regulation of behavioral responses to environmental stimuli.
Chronic exposure to cocaine, or other substances of abuse, induces persistent changes in 
genome-wide transcriptional profiles in the brain’s reward circuitry, resulting in long-lasting 
behavioral abnormalities that characterize drug addiction1. Recent evidence suggests that 
cocaine-induced alterations in gene expression are mediated, in part, by direct regulation of 
the chromatin modifying machinery and associated transcription factor complexes2–4. Data 
now indicate a prominent role for cocaine-mediated reductions in expression and activity of 
G9a, a repressive HMT, and the euchromatic modification that it deposits, H3K9me2 
(dimethylation of Lys9 of histone H3), in nucleus accumbens (NAc) in regulating 
transcriptional, structural, and behavioral plasticity in response to repeated drug 
treatment5–8. Repression of G9a has similarly been observed in postmortem NAc of human 
cocaine addicts (unpaired t-test, effect of addiction: t16 = 2.028, p ≤ 0.05; n = 9/group) (Fig. 
S1 and Supplementary Table 1), indicating a clinically relevant role for G9a and histone 
methylation in human addiction. To date, however, little is known about the cell-type 
specific activities of G9a in NAc in regulating physiological and behavioral responses to 
cocaine. Recently, through targeted deletions of G9a in either Drd1 or Drd2 medium spiny 
neurons (MSNs), Schaefer and colleagues demonstrated a role for this HMT in altering 
behavioral responsiveness to several pharmacological stimuli in a cell-type specific 
manner9, suggesting unique functions for G9a, and associated histone methylation states, in 
the regulation of distinct neuronal phenotypes.
Here, we aimed to better understand G9a’s role in regulating cocaine-induced behaviors 
through segregated analyses of G9a function in Drd1 vs. Drd2 MSNs using a combination of 
genetic, behavioral, and electrophysiological approaches. We found that G9a expression is 
reduced in both Drd1 and Drd2 cells by repeated cocaine exposure, however, opposing 
behavioral responses to cocaine treatment were observed in animals with conditional G9a 
knockout (KO) or adult G9a overexpression in Drd1 vs. Drd2 neurons. Genomic, 
anatomical, and electrophysiological characterizations of G9a revealed a previously 
uncharacterized role for this enzyme, whereby developmental loss of G9a selectively in 
Drd2 MSNs results in a partial striatopallidal to striatonigral ‘switching-like’ phenotype, 
with G9a KO Drd2 cells partly resembling Drd1 cells. Although G9a is a well-known 
mediator of tissue specific transcriptional programs10, our data implicate the enzyme as an 
important regulator of neuronal subtype identity in the adult central nervous system (CNS).
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Results
Cocaine reduces G9a expression in Drd1- and Drd2 MSNs
To assess G9a expression profiles selectively in Drd1 vs. Drd2 MSNs following repeated 
cocaine administration, we employed a cell-type specific translational profiling 
methodology (translating ribosome affinity purification (TRAP))11,12, which allows for 
affinity purification of EGFP-tagged polyribosomal complexes (and associated mRNAs) 
from adult neurons under the control of either Drd1a or Drd2 promoters (Drd1-TRAP; 
G9afl/fl or Drd2; G9afl/fl) (Fig. 1a).
In accordance with previous findings5–7, quantitative polymerase chain reaction (qPCR) 
analyses indicate that G9a expression is significantly reduced in striatum following repeated 
cocaine. This reduction was predominantly observed in Drd2-expressing MSNs (two-way 
ANOVA, cell type x drug, drug: F1,8 = 37.05, p < 0.001; post hoc Bonferroni t-test, effect of 
drug Drd2 MSN: t8 = 6.955, p < 0.001, effect of cell type saline: t8 = 4.856, p < 0.01; n = 3/
group), with a more modest reduction observed in Drd1 cells (unpaired t-test, effect of drug 
Drd1 MSN: t4 = 2.818, p < 0.05; n = 3/group) (Fig. 1b). G9a’s principal binding partner, 
G9a-like protein (Glp), which has also previously been demonstrated to be downregulated 
by repeated cocaine treatment6, was found to be robustly repressed in Drd1 MSNs, with a 
non-significant trend towards downregulation observed in Drd2 cells (unpaired t-test, effect 
of drug Drd1 MSN: t4 = 4.997, p < 0.01/effect of drug Drd2 MSN: t4 = 1.926, p = 0.13; n = 
3/group) (Fig. 1b). Consistent with previous data5,7, the H3K9me3 HMT, Suv39h1, was not 
significantly regulated by repeated cocaine in either cell-type in striatum (Fig. 1b).
G9a oppositely regulates behaviors in D1 vs. D2 MSNs
Since cocaine-mediated reductions in G9a expression in NAc have previously been 
demonstrated to increase cocaine reward5, we next generated selective Drd1 and Drd2 G9a 
KO mice (Drd1-Cre; Drd1-TRAP; G9afl/fl or Drd2-TRAP; G9afl/fl) for direct examination of 
cell-type specific contributions of G9a to cocaine-mediated behaviors. G9a expression was 
significantly reduced following Cre-mediated recombination selectively in Drd1 or Drd2 
cells (two-way ANOVA, cell type x genotype, genotype: F1,9 = 103.6, p < 0.0001; post hoc 
Bonferroni t-test, effect of genotype Drd1 MSN: t9 = 6.399, p < 0.001/Drd2 MSN: t9 = 
7.951, p < 0.001; n = 3–4/group) (Fig. 1c), loss of which resulted in complete (100%) 
ablation of H3K9me2 in Cre-expressing striatal neurons (Fig. 1d). Loss of G9a was 
associated with non-significant trends for reduced expression of Glp in both cell types, with 
no effect on Suv39h1 (Fig. S2). Further work is needed to understand what controls the 
coordinated expression of G9a and Glp and how the balance between them influences neural 
gene expression.
Conditional KO of G9a in Drd2 MSNs phenocopied increased cocaine reward (unpaired t-
test, effect of KO conditioned place preference (CPP): t16 = 2.090, p ≤ 0.05; n = 9/group) 
(Fig. 1e) and locomotor sensitization (LS) (unpaired t-test, effect of KO on LS: t16 = 2.264, 
p < 0.05; n = 9/group) (Fig. 1f) previously observed with global (i.e., both Drd1 and Drd2) 
KO of G9a in NAc5. In contrast, conditional G9a KO in Drd1 MSNs had the opposite effect 
on cocaine CPP and sensitization (unpaired t-test, effect of KO CPP: t16 = 3.482, p < 0.01; n 
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= 8–10/group and LS: t16 = 2.211, p < 0.05; n = 9/group) (Fig. 1e–f) indicating functional 
differences for G9a between Drd1 and Drd2 neuronal subtypes. Lastly, to address the 
functional significance of G9a in adult MSNs, we generated conditional Stopfl/fl Herpes 
simplex viral (HSV) vectors to overexpress G9a selectively in Drd1- or Drd2 MSNs in NAc 
(Fig. 1g). Consistent with robust downregulation of G9a expression in Drd2 MSNs 
following repeated cocaine administration, as well as enhanced behavioral responses to the 
drug, in Drd2 developmental KOs, overexpression of G9a selectively in Drd2 cells reduced 
cocaine CPP (unpaired t-test, effect of Drd2 overexpression: t10 = 2.159, p ≤ 0.05, n = 5–7/
group) (Fig. 1h), suggesting a prominent role for Drd2 G9a activity in regulating cocaine-
mediated reward. Overexpression of G9a in Drd1 MSNs, however, did not affect cocaine 
CPP (unpaired t-test, effect of Drd1 overexpression: t11 = 1.294, p > 0.05, n = 6–7/group), 
further indicating different functions for G9a in these two inter-related cell types.
D2 KO promotes transcriptional unsilencing of D1 genes
To better understand the contribution of G9a to the observed behavioral phenotypes, we next 
employed genome-wide analyses to monitor the impact of repeated cocaine, G9a KO, or 
cocaine plus G9a KO in Drd1 (Supplementary Table 2) vs. Drd2 (Supplementary Table 3) 
MSNs. Similar to previous findings11, we identified a limited set of genes in both cell types 
that display unique regulation by repeated cocaine (Drd1-253 genes and Drd2-239 genes). 
The effects of G9a KO, however, within these two cell types, both in the presence and 
absence of cocaine, were much more pronounced, with many of these genes exhibiting 
unique patterns of transcriptional unsilencing between Drd1 and Drd2 MSNs. The majority 
of these de-repression events were non-overlapping with genes displaying endogenous 
regulation by repeated cocaine in wildtype animals, likely indicating an indirect link 
between the effects of developmental G9a KO and adult cocaine exposure on the behavioral 
phenotypes observed in Fig. 1e–f.
Further analysis of gene expression profiles following G9a KO identified a distinct pattern 
of transcriptional de-repression in Drd2 neurons, whereby expression of Drd1a was 
upregulated, with concomitant reductions in Drd2 expression and enhanced expression of 
numerous genes previously identified as Drd1 enriched (heatmaps: two-way ANOVA, drug 
x genotype for both Drd1 and Drd2 MSNs independently, FDR 0.15) (Fig. 2a). Further 
bioinformatic analysis of genes displaying altered expression profiles between wildtype and 
G9a KO cells indicated highly relevant associations between previously identified Drd1 
enriched and Drd1 associated cocaine-mediated pathways selectively in Drd2 neurons (e.g., 
regulation of the actin cytoskeleton, MAP kinase signaling, etc.) (Fig. 2b). Of particular 
interest was the identification of two genes previously demonstrated to play essential roles in 
the postnatal differentiation of striataonigral neurons, Ebf1 (early B-cell factor 1) and its 
associated binding partner Zfp521 (zinc finger protein 521)13,14. Both genes, which are 
enriched in wildtype Drd1 MSNs, were significantly upregulated following G9a KO in Drd2 
neurons. Similar results were not observed for Drd1 cells lacking G9a. These data suggest 
that repression of G9a in Drd2 cells during development results in the unsilencing of a Drd1-
like transcriptional program that influences an animal’s behavioral responsiveness to 
subsequent cocaine exposure in adulthood.
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Following independent validations of both cocaine’s and G9a’s effects on Drd1a (two-way 
ANOVA, cell type x drug, cell type: F1,8 = 182.4, p < 0.0001; post hoc Bonferroni t-test, 
effect of cell type saline: t8 = 10.67, p < 0.0001/unpaired t-test, effect of cocaine Drd2 MSN: 
t4 = 2.945, p < 0.05/unpaired t-test, effect of genotype Drd2 MSN: t4 = 3.673, p < 0.05; n = 
3/group) (Fig. 2c) and Drd2 (two-way ANOVA, cell type x drug, cell type: F1,8 = 10.32, p ≤ 
0.01; unpaired t-test, effect of cell type saline: t4 = 2.875, p < 0.05, post hoc Bonferroni t-
test, effect of drug: t8 = 3.531, p < 0.05/two-way ANOVA, cell type x genotype, genotype: 
F1,9 = 8.035, p < 0.05; post hoc Bonferroni t-test, effect of genotype: t9 = 3.884, p < 0.01; n 
= 3–4/group) (Fig. 2d) expression selectively in Drd2 neurons, we performed in situ 
hybridization to further examine Drd1a expression in Drd2 MSNs upon G9a KO. Consistent 
with data obtained from our bacTRAP arrays and subsequent qPCR analyses, G9a KO 
selectively in Drd2 MSNs increased the number of Penk+ cells (a marker for Drd2 MSNs) 
that are also Drd1a+ (Fig. 2e).
Next, compiling bioinformatic analyses from our bacTRAP arrays and from two 
independent data sets (bac-TRAP11 and fluorescence activated cell sorting (FACS)13), we 
found that genes across these lists overlap significantly. We statistically categorized genes as 
either Drd1 or Drd2 ‘enriched’ (pairwise comparison between Drd1 and Drd2 control saline, 
p < 0.005) in order to investigate whether a subset of Drd1 enriched genes are indeed 
unsilenced by cocaine, G9a KO or both. Numerous genes were significantly enriched in 
either Drd1 (564 genes, e.g., Drd1a, Eya1 and Pdyn) or Drd2 (921 genes, e.g., Drd2, Penk 
and Adora2a) MSNs (Fig. 3a and Supplementary Tables 4 and 5). We then identified a 
subset of these genes, which were validated as Drd2 enriched, that were significantly 
downregulated in Drd2 MSNs by either repeated cocaine (6.0%), G9a KO (4.7%), or both 
(9.1%) (p < 0.005) (Fig. 3b and Supplementary Tables 6–8), effects that were verified 
through independent qPCR analysis (unpaired t-test, effect of genotype: Hdac5-t4 = 4.382, p 
< 0.05; Fgf11-t4 = 4.019, p < 0.05; Esrra-t4 = 2.607, p ≤ 0.05; Hook2-t4 = 5.391, p < 0.01; 
Ddb2-t4 = 3.062, p < 0.05; n = 3/group) (Fig. 3c). Consistent with the notion that Drd2 
MSNs experience a partial shift in transcriptional identity in response to developmental KO 
of G9a, subsequent analyses also demonstrated that a significant proportion of genes 
identified as Drd1 ‘enriched’ display significant upregulation in Drd2 cells in response to 
repeated cocaine (9.4%), G9a KO (18.1%), or both (20.9%) (p < 0.005) (Fig., 3d and 
Supplementary Tables 9–11), results that were later verified by qPCR (unpaired t-test, effect 
of genotype: Pdyn-t8 = 2.711, p < 0.05; Camk1g-t8 = 3.579, p < 0.01; Gabrb1-t8 = 4.338, p 
< 0.01; Esrrg-t7 = 2.669, p < 0.05; Prkca-t7 = 2.503, p < 0.05; n = 4–6/group) (Fig. 3e).
D2 KO leads to a partial D2 to D1 ‘switching’ phenotype
Given that conditional deletion of G9a enhances Drd1 specific gene expression profiles in 
Drd2 MSNs, we investigated whether G9a KO results in functional adaptations in 
anatomical projections or cellular physiology that may further explain the observed 
behavioral responses to cocaine. Drd2-Cre (control) and Drd2-Cre; G9afl/fl (Drd2 G9a KO) 
mice were stereotaxically injected intra-striatum with adeno-associated virus (AAV)-DIO-
EYFP vectors containing a doubly floxed inverted EYPF marker. With this system, EYFP is 
exclusively expressed in Cre+ MSNs, allowing for cell-type specific tagging for use in 
anatomical tracing and slice physiology. First, to determine whether early postnatal deletion 
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of G9a selectively in Drd2 MSNs alters the neurons’ projection profiles, wildtype and Drd2 
G9a KO animals received successive intra-caudate putamen (CPu) and intra-NAc injections 
of AAV-DIO-EYFP, followed by projection labeling one month after infection. In wildtype 
animals, projection terminals were clearly identified in both the ventral pallidum (VP) and 
the globus pallidus externus (GPe), arising from the ventral and dorsal striatum, 
respectively. Consistent with previous literature, no labeling was observed beyond pallidal 
regions in wildtype Drd2-Cre mice. In Drd2 G9a KO animals, however, clear labeling of 
projection terminals was observed in substantia nigra, a midbrain region traditionally known 
to receive ‘direct pathway’ projections from Drd1, but not Drd2, MSNs originating in 
striatum (Fig. 3f). These data suggest that conditional KO of G9a in Drd2 MSNs leads to 
aberrant transcriptional programs that might influence the appropriate establishment of 
striatal circuitry.
Next, to investigate whether G9a KO-induced expression of Drd1a in Drd2 MSNs results in 
functional Drd1 activity, AAV-DIO-EYFP infected NAc slices (Fig. 4a) from wildtype and 
Drd2 G9a KO animals were incubated in the presence or absence of the Drd1 agonist, 
dihydrexidine hydrochloride, and potassium (K+) currents were measured in voltage clamp. 
Consistent with published reports15, application of the D1 agonist decreased K+ currents at 
hyperpolarized potentials in wildtype Drd1 MSNs, with no evoked responses observed in 
control Drd2 MSNs (Fig. 4b). In G9a KO Drd2 neurons, however, D1 activation 
significantly reduced K+ currents, similar to effects observed in wildtype Drd1 MSNs 
(unpaired t-test, effect of D1 agonist, −130: t13 = 3.086, p < 0.01; −120: t13 = 3.077, p < 
0.01; −110: t13 = 2.613, p < 0.05; n = 7–8/group) (Fig. 4b–c), demonstrating the presence of 
functional D1 receptors on G9a KO Drd2 neurons.
Recent work has established distinct roles for evoked excitability and postsynaptic responses 
between Drd1 and Drd2 MSNs in the regulation of cocaine-mediated behaviors16,17, in 
which increased Drd1, and decreased Drd2, MSN activity or excitatory synaptic function 
increases sensitivity to both the rewarding and locomotor activating effects of cocaine. 
Therefore, we examined directly if G9a plays a cell-type specific role in regulating the 
excitability of NAc MSNs. We began by profiling immediate early gene (IEG) expression, 
as a molecular marker of cellular activity, in Drd1 and Drd2 neurons in control vs. 
conditional G9a mutant mice. We found that several IEGs, which are enriched in Drd1 
MSNs at baseline, are significantly induced in Drd2 neurons upon loss of G9a, with either 
opposite or insignificant changes observed in G9a KO Drd1 neurons (e.g., Arc (two-way 
ANOVA, cell type x genotype, interaction: F1,13 = 11.38, p < 0.01; post hoc Bonferroni t-
test, effect of genotype: t13 = 3.538, p < 0.01/unpaired t-test, effect of cell type: t7 = 2.824, p 
< 0.05; n = 3–6/group) and Fos (two-way ANOVA, cell x genotype, interaction: F1,13 = 
17.9, p ≤ 0.001; post hoc Bonferroni t-test, effect of genotype Drd1 MSN: t13 = 2.704, p < 
0.05; Drd2 MSN: t13 = 3.356, p < 0.05/effect of cell type control: t13 = 3.192, p < 0.05; n = 
3–6/group)). Also, consistent with previous data5, G9a KO from Drd2 MSNs increased basal 
expression of ΔFosB (unpaired t-test, effect of genotype Drd2 MSN: t8 = 3.339, p ≤ 0.01; n 
= 4–6/group), a splice product of the IEG FosB, which accumulates in striatum18, primarily 
in Drd1 cells19,20,27, in response to chronic cocaine exposure and has been shown to 
increase drug reward20 (Fig. 4d). Increased ΔFosB and other IEG expression in response to 
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G9a KO exclusively in Drd2 MSNs further suggests a shift towards Drd1 transcriptional re-
programming and altered cellular physiology.
Although observed increases in IEG expression in G9a KO Drd2 MSNs suggest increased 
activity, such changes are difficult to infer, since IEGs can be regulated by cellular signaling 
cascades in the absence of changes in neuronal firing. We thus directly investigated Drd1 
and Drd2 MSN excitability in NAc after conditional G9a KO. We observed a dramatic 
enhancement in neuronal firing in response to current injections selectively in Drd2 neurons 
lacking G9a (unpaired t-test, effect of genotype Drd2 MSN, 50 pA: t29 = 2.846, p < 0.01, 
100 pA: t28 = 2.655, p ≤ 0.01; n = 15–16/group), with no effect seen in G9a KO Drd1 MSNs 
(Fig. 4e–f). Consistent with increased excitability, Drd2 neurons lacking G9a also display a 
reduced threshold to induce the first spike (rheobase) in response to current injections 
(unpaired t-test, effect of genotype: t25 = 2.608, p ≤ 0.01; n = 8–16/group) (Fig. 4g) and 
increased membrane input resistance in the steady state current voltage (I–V) relationship 
(unpaired t-test, effect of genotype Drd2 MSN, −50 pA: t22 = 2.180, p < 0.05, −25 pA: t22 = 
2.269, p < 0.05, 25 pA: t22 = 2.842, p < 0.01; n = 8–16/group) (Fig. 4h–i).
Discussion
Repeated cocaine exposure reduces G9a expression and activity in striatum, leading to 
persistent changes in gene expression, neuronal morphology, and behavior5. Here, we 
demonstrate that G9a expression is downregulated in both Drd1 and Drd2 MSNs, however, 
the functional impact of G9a ablation or overexpression on cocaine-induced behaviors 
segregates by neuronal subtype. Further investigations examining the consequences of 
developmental G9a KO in Drd1 vs. Drd2 neurons demonstrated a previously 
uncharacterized role for G9a in influencing striatal neuron subtype specification. Selective 
G9a KO in Drd2 expressing neurons induces a partial phenotypic switch: by downregulating 
certain striatopallidal and de-repressing certain striatonigral enriched genes, and by altering 
the axonal projection profiles and functional D1 receptor responsiveness in Drd2 neurons. 
This partial Drd2-Drd1 ‘switching’ phenotype is associated with enhanced sensitivity to the 
rewarding and locomotor activating effects of cocaine. Collectively, our results provide 
novel insight into the role of cell-type specific chromatin regulatory mechanisms in the 
development of behavioral plasticity to cocaine and reveal a role for G9a in controlling 
neuronal subtype identity during development.
G9a has previously been shown to suppress neuronal genes in non-neuronal cells through 
repressive complex associations with RE1 silencing transcription factor (REST) and 
Mediator, a multiprotein interface between RNA polymerase II and locus specific 
transcription factors21. To our knowledge, however, a role for G9a in cell-type specification 
within a given tissue has not yet been demonstrated. Here we provide direct evidence that 
G9a mediated silencing, likely coupled to its euchromatic HMT activity, not only controls 
tissue specific gene expression programs, but also the specification of closely related 
neuronal subtypes within the same tissue (e.g., Drd1 vs. Drd2 MSNs of striatum). Although 
Drd1 vs. Drd2 MSNs have previously been shown to differentially express numerous genes, 
many of which contribute to their cellular identities and distinct functional outputs11,13, the 
mechanisms controlling such distinct fates have remained unclear. The Drd2-to-Drd1 
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phenotypic switch mediated by G9a KO is obviously not complete: the changes observed 
here in transcriptional profiles and anatomical projections are partial. Moreover, while G9a 
KO in Drd2 MSNs increased their excitability, previous work has shown that Drd1 MSNs 
are less excitable than Drd2 MSNs22. Thus, G9a is likely only one of many chromatin 
regulatory proteins involved in establishing MSN cell-type specificity. Nevertheless, it is 
becoming increasingly clear that alterations in G9a, both developmentally and in the adult 
CNS, contribute significantly to neuronal function. It also must be noted that G9a may 
control cell function through mechanisms other than its HMT activity10. Moving forward, it 
will be important to further dissect the molecular mechanisms of G9a action in the CNS 
during periods of neurodevelopment and in adult brain in response to environmental stimuli.
Our findings suggest a disassociation between G9a’s roles during neurodevelopment in 
regards to mediating neuronal subtype specification, and its function in adult brain as a 
modulator of stimulus-induced gene expression. Although both developmental KO of G9a, 
and endogenous repression of G9a in adult brain following repeated cocaine, result in 
altered behavioral responses to the drug, it appears that the underlying molecular 
mechanisms are distinct. For example, repeated exposure to cocaine has been shown to 
increase dendritic spine density of NAc MSNs23–26; this phenomenon is thought to 
contribute to an animal’s increased behavioral responsiveness to cocaine and has been 
linked directly to suppression of G9a5. This response—both increased dendritic spines and 
suppression of G9a5—is mediated by ΔFosB, which forms a negative feedback loop with 
G9a during chronic cocaine exposure. Of intrigue is the recent observation that ΔFosB 
persistently accumulates, and thereby promotes increased dendritic spine density, 
exclusively in Drd1 MSNs in response to repeated cocaine19,27,28, suggesting a vital role for 
Drd1 specific G9a repression in the adult in the potentiation of cocaine-induced behaviors. 
That deletion of G9a from Drd1 MSNs during development results in an opposite behavioral 
phenotype likely reflects a developmental phenomenon.
Although G9a is also reduced in Drd2 MSNs in response to cocaine, the behavioral 
consequences of this effect in adult NAc are less clear. This is because the dramatic 
developmental abnormalities seen in Drd2 neurons upon loss of G9a make it difficult to 
infer anything about the function of this enzyme in the adult. On the other hand, the 
dramatic suppression of G9a in adult Drd2 MSNs in response to chronic cocaine, and the 
ability of G9a overexpression in Drd2 MSNs of adult animals to suppress cocaine reward, 
nevertheless suggest that G9a also regulates cocaine action via this cell type. The 
developmental effects of G9a KO in Drd2 MSNs raise the interesting question of whether 
similar abnormalities might be induced in adult neurons by cocaine. We believe that this is 
unlikely given the timeframe in which rodent studies have been conducted, however, it is 
difficult to truly gauge the impact of long-term repression of G9a by cocaine. For example, 
~1 week of cocaine exposure downregulates G9a expression in striatum, an effect which 
persists for several days during withdrawal5, but this may not constitute enough time to 
permit deficits in neural cell-type specification seen upon developmental deletion of the 
gene. Therefore, future studies, involving cell-type specific KO of G9a in adult animals, will 
be needed to further uncover distinct functional roles of the enzyme in Drd1 vs. Drd2 MSNs 
in response to cocaine exposure.
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Interestingly, chronic cocaine exposure has been shown to reduce the expression and 
functionality of Drd2 in striatum29, a phenomenon that is believed to contribute to increased 
drug reward and drug seeking behavior30. These findings have recently been supported by 
cell-type specific optogenetic dissections of Drd1 vs. Drd2 MSNs in mouse NAc: Lobo et. 
al. demonstrated that increasing the firing of Drd1 MSNs increases cocaine reward and 
locomotor sensitization, while activation of Drd2 MSNs exerts the opposite effects16. Our 
current data are in direct agreement with these previous studies, as we too observed cocaine-
mediated alterations in dopamine receptor expression in striatum consistent with increased 
Drd1 tone: conditional G9a KO selectively from Drd2 neurons results in the unsilencing of 
Drd1 specific gene expression profiles and functional Drd1 activity in these cells, associated 
with increases in cellular excitability and behavioral responsiveness to cocaine, thus 
mimicking those effects seen via optogenetic stimulation of Drd1 MSNs.
In conclusion, our data demonstrate that G9a contributes to the specification of striatal MSN 
subtypes during development and that such actions have prominent effects on cocaine 
sensitivity. We also provide a genome-wide exploration of genes in Drd1 vs. Drd2 MSNs 
that show abnormal regulation in response to repeated cocaine administration as a 
consequence of the cell-type specific loss of G9a during this developmental period. 
Although a master regulator of gene expression and euchromatic silencing, G9a also appears 
to play an important role in the CNS in guiding fundamental aspects of neuronal subtype 
identity and, therefore function, in adult brain. Gaining a broader understanding of the 
physiological and behavioral consequences of chromatin dysregulation during early 
neurodevelopment will aid in the evolution of novel therapeutics aimed at treating addiction 
and other devastating psychiatric disorders.
Online Methods
Animals
Mice were housed at four to five per cage with a 12-hour light/dark cycle (lights on from 
0700 to 1900 hours) at constant temperature (23°C) with ad libitum access to food and 
water. All animal protocols were approved by IACUC at UT Southwestern Medical Center, 
Mount Sinai, and The Rockefeller University.
Generation of Transgenic Mouse Lines
Drd1- and Drd2-Cre mice (EY262 and ER44, Gensat31, and Drd1-, and Drd2-TRAP mice11 
were bred to G9afl/fl mice 32 to generate Drd1-Cre; G9afl/fl and Drd2-Cre; G9afl/fl for 
electrophysiological analysis, as well as Drd1-Cre; Drd1-TRAP; G9afl/fl, Drd1-TRAP; 
G9afl/fl, Drd2-Cre; Drd2-TRAP; G9afl/fl and Drd2-TRAP; G9afl/fl mice for cell-type specific 
ribosomal-associated RNA purification as previously described9. Drd2-Cre; Drd2-eGFP; 
G9afl/fl and Drd2-eGFP; G9afl/fl used for immunofluorescence studies were generated as 
previously described9. All mice were backcrossed to the C57Bl/6 background for >5 
generations, and genotyping was performed as previously described.
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Drugs
Cocaine-HCl was obtained from Sigma-Aldrich and used at a concentration of 20 mg/kg/i.p. 
Mice were immediately returned to their home cage after each injection, unless otherwise 
stated.
Quantifying Protein Expression from Human Postmortem Brain
Postmortem human brain tissue was obtained from the Quebec Suicide Brain Bank (IRB 
approval from Douglas Mental Health University Institute, Montreal, Quebec, Canada). 
Tissue preservation proceeded as described previously33. Once obtained, brains were placed 
on wet ice and transported to the Quebec Suicide Brain Bank facilities. Once dissected, 
tissues were flash frozen in 2-methylbutane at −40°C. All frozen tissues were kept 
separately in plastic bags at −80°C for long-term storage. Specific brain regions were later 
sectioned from frozen coronal slices.
This cohort was composed of one female and 17 male subjects, ranging in age between 18 
and 66 years. All subjects died suddenly without protracted medical illness or extended 
agonal states. For each case, the cause of death was determined by the Quebec Coroner 
Office, and toxicological screens were conducted to obtain information on medication and 
illicit substance use at the time of death. The subject group consisted of 9 individuals who 
met the Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of 
Mental Disorders-IV) Axis I Disorders: Clinician Version (SCID-I) criteria for cocaine 
dependence. The control group comprised 9 subjects with no history of cocaine dependence 
and no major comorbid psychiatric diagnoses. Groups were matched for subject age, 
postmortem interval, and pH. For all subjects, psychological autopsies were performed, 
giving us access to detailed information on psychiatric and medical histories, as well as 
other relevant sociodemographic and clinical data (Supplementary Table 1).
To quantify G9a protein expression (Fig. S1), frozen NAc tissue was homogenized in 30 μL 
of homogenization buffer (320 mM sucrose, 5 mM Hepes buffer, 1% SDS, phosphatase 
inhibitor cocktails I and II (Sigma) and protease inhibitors (Roche) using an ultrasonic 
processor (Cole Parmer). Protein concentrations were determined using a DC protein assay 
(Bio-Rad), and 50 μg of protein was loaded onto 4–15% gradient Tris-HCl polyacrylamide 
gels for electrophoresis fractionation (Bio-Rad). Samples were next transferred to 
nitrocelluose membranes and blocked in Odyssey® blocking buffer (Li-Cor). Blocked 
membranes were incubated overnight at 4°C in primary antibody (1/500 G9a, Millipore 
09-071) in Odyssey® blocking buffer. After washing with TBST, membranes were 
incubated with IRDye® secondary antibodies (1/5000 to 1/10000; Li-Cor) dissolved in 
Odyssey® blocking buffer for 1 hr at room temperature. Blots were then imaged with the 
Odyssey® Infrared Imaging system (Li-Cor) and were quantified by densitometry using 
ImageJ (NIH). The amount of protein loaded into each lane was normalized to levels of 
glyceraldehyde 3-phosphate dehydrogenase (1: 5000, Millipore MAB374).
TRAP, qPCR & Arrays
Polyribosome associated mRNAs from 2–5 month old, age and sex matched Drd1-Cre; 
Drd1-TRAP; G9afl/fl and Drd1-TRAP; G9afl/fl, Drd2-Cre; Drd2-TRAP; G9afl/fl and Drd2-
Maze et al. Page 10
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
TRAP; G9afl/fl mice (n = 2–4 mice/genotype/drug treatment, 2 hours after the last of eight 
repeated cocaine injections of 20 mg/kg/day) were obtained as previously described9,11,12. 
EGFP labeled ribosomes and associated mRNAs were immunoprecipitated using a mix of 
two monoclonal anti-GFP antibodies (50 μg of clones #19C8 and #19F7 for each IP, 
available at Sloan-Kettering Monoclonal Antibody Facility). Purified mRNA was amplified 
and processed for microarray and qPCR analysis using the Affymetrix two-cycle cDNA 
Synthesis kit (Affymetrix) as previously described11,12. Affymetrix Mouse Genome 430 2.0 
arrays were used in all experiments. Information regarding the array design and features can 
be found at www.affymetrix.com. Mouse Genome 430 2.0 arrays were scanned using the 
GeneChip Scanner 3000 (Affymetrix) and globally scaled to 150 using the Affymetrix 
GeneChip Operating Software (GCOS v1.4).
cDNA was quantified by qPCR with SYBR Green. Each reaction was run in duplicate and 
analyzed using the ΔΔCt method as previously described34. Glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh) was used as a normalization control and was not found to be altered 
by any manipulations described throughout the manuscript. See supplementary Table 12 for 
mRNA primer sequences.
Behavior
Conditioned Placed Preference (CPP)—CPP was conducted as previously described5. 
Briefly, 8–12 week old Drd1-TRAP; G9afl/fl, Drd1-Cre; Drd1-TRAP; G9afl/fl, Drd2-TRAP 
and Drd2-Cre; Drd2-TRAP; G9afl/fl mice were placed into conditioning chambers 
consisting of three distinct environments. Mice displaying significant preference for either 
of the two conditioning chambers were excluded (<5% of all animals). Conditioning groups 
were subsequently balanced to adjust for chamber bias. On conditioning days (subsequent 4 
days), animals were injected with either saline (days 1 and 3) or cocaine (10 mg/kg, i.p.) 
(days 2 and 4) and were then confined to one chamber in the afternoon for 30 minutes. On 
the test day, animals were placed back into the CPP apparatus without treatment for 20 
minutes and evaluated for which side they preferred. Locomotor responses to cocaine were 
assessed by beam break analysis in the cocaine-paired chambers to ensure the effectiveness 
of drug treatment. For all groups, baseline locomotor responses to saline were assessed to 
ensure that locomotion was not affected by genotype (data not shown). For HSV CPP 
experiments (Fig. 1i), an accelerated conditioning paradigm was employed. Briefly, 48 hr 
after surgery, mice were injected with saline (day 1 morning, day 2 night) or cocaine (day 1 
night, day 2 morning) during which they were confined to one chamber for 30 minutes as 
described. On day 3, CPP testing proceeded as stated previously. Behaviors were assessed 
during the animals’ light cycle.
Locomotor Activity—8–12 week old Drd1-TRAP; G9afl/fl, Drd1-Cre; Drd1-TRAP; 
G9afl/fl, Drd2-TRAP and Drd2-Cre; Drd2-TRAP; G9afl/fl mice injected once daily for 14 
days with cocaine (20 mg/kg, i.p.) and immediately returned to their home cages. 1 week 
later, animals were habituated in locomotor boxes for 60 min and then monitored for 
locomotor activity after a single saline injection (60 minutes) using the Photobeam Activity 
System (San Diego Instruments). In accordance with previous findings9,35, all animals 
habituated normally and displayed similar responses to a saline injection. Next animals were 
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injected with a low dose of cocaine (5 mg/kg, i.p.) and monitored for locomotor activity for 
30 minutes. Note that all animals used in this study displayed enhancements in locomotor 
activity in response to cocaine above that of saline treated controls. Data are presented as a 
percent control of total beam breaks over the course of the 30 minute test comparing mutant 
mice to respective wildtype littermates. Locomotor behaviors were assessed during the 
animals’ light cycle.
TRAP Array Analyses
Affymetrix Probe Sets Summarization—Probe level intensity files (CEL) were 
imported into Affymetrix’s Expression Console (v1.1) program for analysis. The RMA 
algorithm was used for normalization and probe level summarization files (CHP) were then 
exported for further analysis. Only 1 of 30 files was filtered out, as it failed default quality 
thresholds. Two negative control files were also removed, leaving 27 files remaining across 
the three design factors.
Differential Analysis—Two-way ANOVAs among different genotypes and experimental 
treatments were performed for each cell type individually to identify genes displaying 
differential expression. For each gene, three F-tests were performed for genotype, treatment 
and their interaction. All F-test results were subjected to multiple testing corrections using 
the Benjamini-Hochberg procedure. FDR < 15% was used as a cutoff to select genes for the 
heatmaps displayed in Fig. 2.
Pairwise comparisons were performed between two groups of any combination of the three 
factors using student t-tests. A p-value of < 0.005 was used as a cutoff. This approach was 
first used to compare compiled data sets: 1) control-saline-Drd1 vs. control-saline-Drd2 
from our bacTRAP arrays; 2) control-saline-Drd1 vs. control-saline-Drd2 from Heiman et 
al.11; and 3) Drd1 vs. Drd2 FACS arrays from Lobo et al.14 to identify cell-type specific 
gene expression enrichment under basal conditions. It was then used to compare the effects 
of cocaine treatment, G9a KO, or a combination of the two with respective cell-type specific 
saline controls. These comparisons were performed to identify genes displaying increased 
expression of Drd1 enriched genes or decreased expression of Drd2 enriched genes in Drd2 
MSNs following different perturbations.
Immunohistochemistry
8- to 12-week-old sex- and age-matched Drd2-Cre; Drd2-eGFP; G9afl/fl, and their 
respective littermate controls were anesthetized with pentobarbital and transcardially 
perfused with 10 ml of phosphate-buffered saline (PBS) followed by 50 ml of 4% 
paraformaldehyde (PFA) in PBS. Brains were processed as previously described9 and 
coronally sectioned at either 12 μm thickness on a Cryostat (Fig. 1d) or 35 μm thickness on a 
microtome following cryoprotection in 30% sucrose (Fig. 1h). GFP (1:5000, Abcam ab6556 
or 1:8000, Aves Labs, Inc. GFP-1020), Flag M2 (1:400, Sigma F1804) and H3K9me2 
(1:500, Abcam ab1220) were visualized using indirect immunofluorescence analysis (Alexa 
Fluor 647/546/488 labeled goat anti-mouse/anti-rabbit IgGs (H+L) dilution 1:500, 
Invitrogen Corporation). Draq5 (Biostatus Limited) or DAPI (Life Technologies) were used 
to counterstain the nucleus and sections were mounted using Prolong Gold antifade 
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(Invitrogen) before being imaged on a LSM 710 confocal microscope (Zeiss). For validation 
of H3K9me2 knockdown in Drd2 G9a KO MSNs, cells were counted from 5 independent 
images/genotype (control: 545 Draq-5+ cells and Mutant: 537 Draq-5+ cells). Data were 
recorded as the percentage of Drd2+ cells co-expressing H3K9me2 in wildtype vs. KO 
striatum.
Drd2-Cre and Drd2-Cre; G9afl/fl mice, which had received stereotaxic intra-NAc injections 
1 month prior with adeno-associated virus (AAV)-DIO-EYFP, were sedated with a lethal 
dose of chloral hydrate and perfused with PBS followed by 4% PFA before being analyzed 
by single or double immunohistochemistry for GFP (EYFP) and Cre recombinase. Briefly, 
brains were post-fixed and then incubated at room temperature overnight in 30% sucrose in 
PBS before being coronally sectioned at 35 μm (for projection tracing, brains were sectioned 
in the sagittal plane on a cryostat (Leica)). Free-floating NAc sections were washed with 
PBS, blocked (3% normal donkey serum, 0.3% tritonX, PBS) for 1 hour, and later incubated 
with anti-GFP (to detect EYFP expression) (1:5000–8000, GFP 1020, Aves Labs, Inc) and 
anti-Cre recombinase (1:1000, Millipore MAB3120) antibodies in blocking solution. 
Following overnight incubation in primary antibody, NAc sections were rinsed 3 times for 
10 minutes each with PBS, followed by incubation in 1:500 donkey anti-chicken Cy2 and 
1:500 donkey anti-mouse Cy3 fluorescent-coupled secondary antibodies (Jackson 
ImmunoResearch) in blocking solution for 1 hour (for tracing studies: Alexa Fluor 488 
labeled goat anti-chicken 1:1000). Sections were subsequently washed 3x with PBS. Finally, 
NAc sections were mounted onto superfrost plus slides, allowed to dry and were then 
dehydrated in ethanol and cleared with Citrisolv. Slides were coverslipped in DePex and 
sections were imaged on either LSM 710 or Olympus confocal microscopes. For tracing 
studies, NAc, dorsal striatum, VP, GPe, axons to midbrain and SN were imaged.
Viral Mediated Gene Transfer
Following ketamine (100 mg/kg)/xylazine (10 mg/kg) induced anesthesia, Drd1-Cre, Drd1-
Cre; G9afl/fl, Drd2-Cre and Drd2-Cre; G9afl/fl mice were placed in stereotaxic instruments, 
and cranial surfaces were exposed. 33 gauge syringe needles were used to infuse 0.5 μl of 
virus bilaterally into NAc at a 10° angle (AP + 1.6; ML + 1.5; DV – 4.4) at a rate of 0.1 
μl/min (for successive CPu injections, after NAc injections were complete, needles were 
raised +1.0 mm DV and virus was infused as previously indicated). Animals receiving 
AAV-DIO-EYFP injections were allowed to recover for 4 weeks following surgery. 
Animals receiving HSV-GFP-Stopfl/fl-mCherry/hG9a viruses were allowed to recover for 48 
hours prior to CPP training. These times are consistent with periods of maximal viral-
mediated transgene expression5,16.
Fluorescent in situ hybridization (FISH)
Briefly, PCR products generated using primers (IDT technology) with an attached Sp6 or T7 
polymerase sequence were used for in vitro transcription of Drd1a-UTP-Digoxigenin or 
Penk-UTP-Biotin (Roche Diagnostics) labeled RNA probes. The following primer 
sequences were used:
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Drd1a Forward T7-
CTGTAATACGACTCACTATAGGGCAGATCGGGCATTTGGAGAGAT
Drd1a Reverse Sp6-
GGGATTTAGGTGACACTATAGAATGACCAAGACAGCCACCAAG
Penk Forward T7-CTGTAATACGACTCACTATAGGGTTCCTGAGGCTTTGCACC
Penk Reverse Sp6-
GGGATTTAGGTGACACTATAGAATCACTGCTGGAAAAGGGC
14 μm thick cryosectioned tissue was hybridized with riboprobes overnight, followed by 
incubation with peroxidase antibodies directed against digoxigenin (Roche) and biotin 
(Jackson Immunoresearch). Amplification of the peroxidase-based antibodies was 
performed with the TSA Plus Fluorescent Kit (Perkin Elmer) for 8 minutes during which 
time fluorescein was deposited on Drd1a-labeled cells and tetramethylrhodamine was 
deposited on Penk-labeled cells. Slides were mounted using Vectamount with DAPI (Vector 
Laboratories) and imaged using a Leica upright fluorescent microscope. Sense probes were 
used to control for non-specific labeling.
In Vitro Patch-Clamp Electrophysiology
Whole cell recordings were obtained from NAc shell MSNs in acute brain slices from Drd1-
Cre, Drd1-Cre; G9afl/fl, Drd2-Cre and Drd2-Cre; G9afl/fl mice that had been stereotaxically 
injected intra-NAc with AAV-DIO-EYFP. To minimize stress and to obtain healthy NAc 
slices, mice were anesthetized and perfused immediately for 40–60 seconds with ice-cold 
aCSF (artificial cerebrospinal fluid), which contained 128 mM NaCl, 3 mM KCl, 1.25 mM 
NaH2PO4, 10 mM D-glucose, 24 mM NaHCO3, 2 mM CaCl2, and 2 mM MgCl2 
(oxygenated with 95% O2 and 5% CO2, pH 7.4, 295–305 mOsm). Acute brain slices 
containing NAc MSNs were cut using a microslicer (DTK-1000, Ted Pella) in cold sucrose-
aCSF, which was derived by fully replacing NaCl with 254 mM sucrose and saturated by 
95% O2 and 5% CO2. Slices were maintained in a holding chamber with aCSF for 1 hour at 
37°C. Patch pipettes (3–5 mΩ) for whole cell current-clamp and voltage-clamp recordings 
were filled with internal solution containing the following: 115 mM potassium gluconate, 20 
mM KCl, 1.5 mM MgCl2, 10 mM phosphocreatine, 10 mM HEPES, 2 mM magnesium 
ATP, and 0.5 mM GTP (pH 7.2, 285 mOsm). Whole cell recordings were carried out using 
aCSF at 34°C (flow rate = 2.5 ml/min). For all recordings, responses were measured using 
the Multiclamp 700B amplifier and data acquisition was performed in pClamp 10 
(Molecular Devices). Series resistance was monitored during experiments, and membrane 
currents and voltages were filtered at 3KHz (Bessel filter). To measure the intrinsic 
membrane properties of NAc MSNs, whole cell recordings were carried out in current clamp 
mode.
For measurements of neuronal excitability, current was injected in incremental steps (step 50 
pA; range 0 to 100 pA). Measurements of input resistance (current-voltage response) were 
also performed with incremental current steps (steps 25 pA; range 50 to −200 pA). For all 
recordings, cells were held at −70 mV. To measure the effects of the D1 agonist 
(Dihydrexidine – DHX; 10uM) on potassium currents in Drd2-Cre G9a KO neurons, 
Maze et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
recordings were performed in voltage clamp mode (neurons held at −70 mV). To isolate 
potassium currents during whole-cell recordings, tetrodotoxin (TTX; 1 μM), cadmium 
chloride (CdCl2; 200 μM), kynurenic acid (1 mM), and picrotoxin (100 μM) were added to 
the bath aCSF solution in order to block sodium channels, calcium channels, glutamate 
receptors and GABAA receptors, respectively. Potassium current response to voltage steps 
(−40 to −130 mV) was measured in the absence and presence of the D1 agonist.
Statistics
For all qPCR analyses, two-way ANOVAs with Bonferroni multiple comparisons (*), or 
unpaired student’s t-tests (two-tailed) (#), were performed to determine significance. 
Student’s t-tests were used for other comparisons including behavioral experiments (mutant 
mice vs. wildtype littermates (*)) and all electrophysiological measurements (*). Microarray 
analyses were performed as described above. All values included in the figure legends 
represent mean ± SEM (*/#p ≤ 0.05; **/##p < 0.01, ***p < 0.001, ****p < 0.0001). Detailed 
statistical analyses are provided throughout the main text.
Sample Sizes—No statistical methods were used to pre-determine sample sizes but our 
sample sizes are similar to those reported in previous publications from our laboratory. 
Furthermore, variance was found to be similar between groups being statistically compared.
Blinding—With the exception of qPCR and microarray analyses, all experiments were 
conducted with the experimenter blind to genotype.
Randomization—For all molecular, behavioral and electrophysiological experiments, 
animals were randomly assigned to groups (segregated by genotype). Furthermore, for all 
molecular experiments, tissue collected from treated animals was randomly pooled to 
provide ample tissue for biochemical procedures and to minimize variance across cohorts.
Normality Testing—Although normality was not formally tested for every experiment, 
observations of the data suggest that sample distributions do not deviate significantly from 
that of a normal distribution curve.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported by grants from the National Institute on Drug Abuse and National Institute of Mental 
Health, among others: P01DA08227 and P50MH96890 (E.J.N), MH092306 (D.C., M.H.H.) and J&J/IMHRO 
(M.H.H.), and DA025962 (A.S.). The following provided additional support for this work: NARSAD Young 
Investigator Award (18194) (A.S.) and the Seaver Foundation (A.S.).
References
1. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related 
learning and memory. Annu Rev Neurosci. 2006; 29:565–98. [PubMed: 16776597] 
Maze et al. Page 15
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
2. Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nature reviews 
Neuroscience. 2011; 12:623–37. [PubMed: 21989194] 
3. Maze I, Nestler EJ. The epigenetic landscape of addiction. Annals of the New York Academy of 
Sciences. 2011; 1216:99–113. [PubMed: 21272014] 
4. Rogge GA, Wood MA. The role of histone acetylation in cocaine-induced neural plasticity and 
behavior. Neuropsychopharmacology: official publication of the American College of 
Neuropsychopharmacology. 2013; 38:94–110. [PubMed: 22910457] 
5. Maze I, et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. 
Science. 2010; 327:213–6. [PubMed: 20056891] 
6. Covington HE 3rd, et al. A role for repressive histone methylation in cocaine-induced vulnerability 
to stress. Neuron. 2011; 71:656–70. [PubMed: 21867882] 
7. Kennedy PJ, et al. Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in 
histone methylation. Nature Neuroscience. 2013; 16:434–40. [PubMed: 23475113] 
8. Sun H, et al. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 
dimethylation in the nucleus accumbens. The Journal of neuroscience: the official journal of the 
Society for Neuroscience. 2012; 32:17454–64. [PubMed: 23197736] 
9. Schaefer A, et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor 
complex. Neuron. 2009; 64:678–91. [PubMed: 20005824] 
10. Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes & 
development. 2011; 25:781–8. [PubMed: 21498567] 
11. Heiman M, et al. A translational profiling approach for the molecular characterization of CNS cell 
types. Cell. 2008; 135:738–48. [PubMed: 19013281] 
12. Doyle JP, et al. Application of a translational profiling approach for the comparative analysis of 
CNS cell types. Cell. 2008; 135:749–62. [PubMed: 19013282] 
13. Lobo MK, Karsten SL, Gray M, Geschwind DH, Yang XW. FACS-array profiling of striatal 
projection neuron subtypes in juvenile and adult mouse brains. Nat Neurosci. 2006; 9:443–52. 
[PubMed: 16491081] 
14. Lobo MK, Yeh C, Yang XW. Pivotal role of early B-cell factor 1 in development of striatonigral 
medium spiny neurons in the matrix compartment. Journal of neuroscience research. 2008; 
86:2134–46. [PubMed: 18338816] 
15. Podda MV, Riccardi E, D’Ascenzo M, Azzena GB, Grassi C. Dopamine D1-like receptor 
activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting 
inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent 
mechanism. Neuroscience. 2010; 167:678–90. [PubMed: 20211700] 
16. Lobo MK, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine 
reward. Science. 2010; 330:385–90. [PubMed: 20947769] 
17. Kim J, Park BH, Lee JH, Park SK, Kim JH. Cell type-specific alterations in the nucleus accumbens 
by repeated exposures to cocaine. Biological psychiatry. 2011; 69:1026–34. [PubMed: 21377654] 
18. Hope BT, et al. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in 
brain by chronic cocaine and other chronic treatments. Neuron. 1994; 13:1235–44. [PubMed: 
7946359] 
19. Lee KW, et al. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-
containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci U S A. 2006; 
103:3399–404. [PubMed: 16492766] 
20. Nestler EJ. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R 
Soc Lond B Biol Sci. 2008; 363:3245–55. [PubMed: 18640924] 
21. Ding N, et al. Mediator links epigenetic silencing of neuronal gene expression with x-linked mental 
retardation. Mol Cell. 2008; 31:347–59. [PubMed: 18691967] 
22. Gertler TS, Chan CS, Surmeier DJ. Dichotomous anatomical properties of adult striatal medium 
spiny neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 
2008; 28:10814–24. [PubMed: 18945889] 
23. Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal 
cortex neurons produced by previous experience with amphetamine. J Neurosci. 1997; 17:8491–7. 
[PubMed: 9334421] 
Maze et al. Page 16
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
24. Russo SJ, et al. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine 
reward. J Neurosci. 2009; 29:3529–37. [PubMed: 19295158] 
25. LaPlant Q, et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus 
accumbens. Nat Neurosci. 2010; 13:1137–43. [PubMed: 20729844] 
26. Dumitriu D, et al. Subregional, dendritic compartment, and spine subtype specificity in cocaine 
regulation of dendritic spines in the nucleus accumbens. The Journal of neuroscience: the official 
journal of the Society for Neuroscience. 2012; 32:6957–66. [PubMed: 22593064] 
27. Robison AJ, et al. Behavioral and structural responses to chronic cocaine require a feedforward 
loop involving DeltaFosB and calcium/calmodulin-dependent protein kinase II in the nucleus 
accumbens shell. The Journal of neuroscience: the official journal of the Society for Neuroscience. 
2013; 33:4295–307. [PubMed: 23467346] 
28. Lobo MK, et al. DeltaFosB Induction in Striatal Medium Spiny Neuron Subtypes in Response to 
Chronic Pharmacological, Emotional, and Optogenetic Stimuli. The Journal of neuroscience: the 
official journal of the Society for Neuroscience. 2013; 33:18381–95. [PubMed: 24259563] 
29. Volkow ND, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal 
metabolism in cocaine abusers. Synapse. 1993; 14:169–77. [PubMed: 8101394] 
30. Thanos PK, Michaelides M, Umegaki H, Volkow ND. D2R DNA transfer into the nucleus 
accumbens attenuates cocaine self-administration in rats. Synapse. 2008; 62:481–6. [PubMed: 
18418874] 
31. Gong S, et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial 
chromosome constructs. The Journal of neuroscience: the official journal of the Society for 
Neuroscience. 2007; 27:9817–23. [PubMed: 17855595] 
32. Sampath SC, et al. Methylation of a histone mimic within the histone methyltransferase G9a 
regulates protein complex assembly. Mol Cell. 2007; 27:596–608. [PubMed: 17707231] 
33. Quirion R, et al. Human brain receptor autoradiography using whole hemisphere sections: a 
general method that minimizes tissue artefacts. Synapse. 1987; 1:446–54. [PubMed: 2850625] 
34. Tsankova NM, et al. Sustained hippocampal chromatin regulation in a mouse model of depression 
and antidepressant action. Nat Neurosci. 2006; 9:519–25. [PubMed: 16501568] 
35. Bateup HS, et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor 
behaviors. Proceedings of the National Academy of Sciences of the United States of America. 
2010; 107:14845–50. [PubMed: 20682746] 
Maze et al. Page 17
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. Cocaine regulation of G9a in Drd1 and Drd2 striatal MSNs
(a) Schematic outlining the TRAP approach for purifying cell-type specific polyribosomal 
associated mRNAs for Drd1 vs. Drd2 gene expression analysis. (b) G9a expression is 
significantly reduced in both Drd1 and Drd2 MSNs in striatum in response to repeated 
cocaine. Glp, G9a’s principal binding partner, displays similar regulation to G9a, however 
Suv39h1, an H3K9me3 HMT, was unaffected by cocaine treatment. (c) In comparison to 
wildtype littermate controls, G9a expression is significantly and selectively reduced in Drd1 
and Drd2 MSNs following Cre-mediated recombination resulting in (d) selective loss of 
euchromatic H3K9me2 in these cells (scale bars for representative immunofluorescence 
images equal 20 μm). Such conditional KO of G9a in Drd1 vs. Drd2 MSNs results in distinct 
effects on both (e) cocaine reward (CPP) and (f) the locomotor activating effects of repeated 
cocaine exposure. (g) Representative images (scale bar equals 50 μm) demonstrating cell 
type specific overexpression of G9a (Flag tagged) in Drd2-Cre mice. Both HSV-Stopfl/fl-
mCherry and G9a viruses express GFP irrespective of Cre expression, yet nuclear G9a 
(Flag) expression is only observed in a subpopulation of these MSNs (Drd2-Cre+). (h) Drd2, 
but not Drd1, specific G9a overexpression in adult NAc reduces cocaine CPP. Data are 
presented as averages ± SEM.
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Figure 2. G9a KO alters the transcriptional identity of Drd2 MSNs in striatum
(a) Comparative heatmaps displaying genes significantly regulated in Drd1 vs. Drd2 neurons 
by repeated cocaine, G9a KO, or repeated cocaine plus G9a KO. (b) Bioinformatics analysis 
(Database for Annotation, Visualization and Integrated Discovery (DAVID)) of gene 
expression pathways regulated by cocaine exposure ± G9a KO in Drd1 vs. Drd2 neurons 
demonstrating Drd2-selective enrichment for genes previously shown to be basally enriched 
or regulated by cocaine in Drd1 MSNs. Independent validations of cocaine’s and G9a’s 
impact on (c) Drd1a and (d) Drd2 expression in striatal MSNs reveals opposing patterns of 
regulation, whereby Drd1a is induced and Drd2 is repressed selectively in Drd2 MSNs 
following both repeated cocaine exposure and G9a KO (inset). (e) FISH analysis of Drd2-
Cre vs. Drd2-Cre; G9afl/fl mice reveals increased colocalization of Drd1a (a Drd1 specific 
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gene) and Penk (a Drd2 specific gene) in striatum of Drd2 G9a KOs in comparison to 
wildtype controls. White circles indicate DAPI+ cells co-expressing Drd1a and Penk, and 
red circles indicate DAPI+ cells expressing either Drd1a or Penk, but not both. T7 sense 
controls indicate gene specific labeling for both Drd1a and Penk probes. All images were 
acquired at 40X objective. Data are presented as averages ± SEM.
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Figure 3. Selective loss of G9a in Drd2 MSNs results in the unsilencing of striatonigral specific 
gene expression profiles and abnormal afferent projections
(a) Identification of Drd1 vs. Drd2 enriched gene expression profiles in striatum. (b) 
Numbers of Drd2 enriched genes displaying significant downregulation in Drd2 MSNs 
following repeated cocaine, G9a KO, or both. (c) Validation of Drd2 enriched genes 
downregulated by G9a KO selectively in Drd2 MSNs. (d) Numbers of Drd1 enriched genes 
displaying significant upregulation in Drd2 MSNs following repeated cocaine, G9a KO, or 
both. (e) Validation of Drd1 enriched genes upregulated by G9a KO selectively in Drd2 
MSNs. Percentages indicate the number of Drd2 (b) or Drd1 (d) enriched genes displaying 
significant regulation by repeated cocaine, G9a KO, or both, divided by the total number of 
genes enriched within a given cell type. (f) Afferent projection terminal tracing demonstrates 
that selective loss of G9a in Drd2 neurons leads to abnormal ‘direct pathway’ projections to 
midbrain (substantia nigra) from Drd2 G9a KO MSNs in comparison to wildtype controls. 
Data are presented as averages ± SEM.
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Figure 4. Ablation of G9a in Drd2 MSNs results in a functional Drd2-Drd1 ‘switching’ 
phenotype and enhanced cell excitability
(a) Representative immunofluorescence image of AAV-DIO-EYFP expression in Drd2-Cre 
expressing MSNs in NAc (scale bars equal 100 μm and 20 μm respectively for low (left) vs. 
high (right) power images). (b) Representative traces of K+ channel mediated currents in 
voltage clamp in response to hyperpolarizing voltage steps for putative Drd1 vs. EYFP+ 
Drd2 MSNs ± G9a KO in the absence or presence of the D1 agonist dihydrexidine 
hydrochloride. (c) Quantification of normalized K+ current across multiple voltage steps 
indicates that D1 agonism attenuates K+ currents at hyperpolarized potentials in both G9a 
KO Drd2 MSNs and in Drd1 MSNs, but not in wildtype Drd2 neurons. (d) IEG analysis in 
Drd1 vs. Drd2 MSNs ± G9a KO demonstrates a selective upregulation of activity-dependent 
genes in Drd2 MSNs lacking G9a. (e) Representative traces of spike number in response to 
current injections over time as a measure of intrinsic neuronal excitability. Whole cell 
quantification of current-induced spike number in Drd1 vs. Drd2 MSNs ± G9a KO indicates 
that G9a ablation selectively from Drd2 neurons results in increased cellular excitability (f) 
and reduced threshold for the first spike (rheobase) (g). (h) Representative voltage traces in 
response to current injections. (i) Consistent with enhanced excitability of Drd2 neurons 
following G9a KO, increased membrane resistance in the I–V relationship was observed, 
with no effects seen in Drd1 MSNs, indicating increased excitability of G9a KO Drd2 
neurons. Data are presented as averages ± SEM.
Maze et al. Page 22
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
